These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3057642)

  • 1. Interferons in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon therapy in multiple myeloma].
    Ludwig H; Scheithauer W; Kührer I; Kuzmits R; Gisslinger G; Linkesch W; Zielinski C; Fritz E
    Onkologie; 1988 Aug; 11(4):192-6. PubMed ID: 3054670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon and multiple myeloma.
    Lauta VM
    Med Oncol; 1995 Mar; 12(1):63-9. PubMed ID: 8542250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Semin Oncol; 1986 Sep; 13(3):334-40. PubMed ID: 2429367
    [No Abstract]   [Full Text] [Related]  

  • 5. The therapy of multiple myeloma with the interferons.
    Bonnem EM
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():35-41. PubMed ID: 2449280
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
    Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
    N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma.
    Preis P; Scheithauer W; Fritz E; Zielinski C; Kuehrer I; Cortelezzi A; Polli E; Baldini L; Pirker R; Kriegisch A
    Onkologie; 1989 Feb; 12(1):27-9. PubMed ID: 2654788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons in the treatment of multiple myeloma.
    Bergsagel DE; von Wussow P; Alexanian R; Avvisati G; Bataille R; Barlogie B; Borden E; Caligaris-Cappio F; Deicher H; Durie BG; Giles F; Huhn D; Klein B; Kyle RA; Ludwig H; Mellstedt H; Peest D; Salmon SE; Westin J
    J Clin Oncol; 1990 Aug; 8(8):1444-5. PubMed ID: 2380763
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid response to recombinant interferon alpha 2B and high-dose prednisone in multiple drug-resistant multiple myeloma.
    Wahlin A; Holm J
    Eur J Haematol; 1989 Oct; 43(4):352-4. PubMed ID: 2583262
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferon in the treatment of multiple myeloma].
    Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
    Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whither interferon for myeloma and other hematologic malignancies?
    Alexanian R; Weber D
    Ann Intern Med; 1996 Jan; 124(2):264-5. PubMed ID: 8534004
    [No Abstract]   [Full Text] [Related]  

  • 12. Pegylated-interferon induced severe bone marrow hypoplasia in a patient with multiple myeloma receiving thalidomide.
    Gómez-Rangel JD; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
    Am J Hematol; 2003 Dec; 74(4):290-1. PubMed ID: 14635214
    [No Abstract]   [Full Text] [Related]  

  • 13. The management of myelomatosis.
    Galton DA; Brito-Babapulle F
    Eur J Haematol; 1987 Nov; 39(5):385-98. PubMed ID: 2446915
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-alpha in the treatment of multiple myeloma.
    Khoo TL; Vangsted AJ; Joshua D; Gibson J
    Curr Drug Targets; 2011 Mar; 12(3):437-46. PubMed ID: 21143148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving strategies for the treatment of myelomatosis.
    Child JA
    Br J Haematol; 1994 Dec; 88(4):672-8. PubMed ID: 7819093
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.
    Costanzi JJ; Cooper MR; Scarffe JH; Ozer H; Grubbs SS; Ferraresi RW; Pollard RB; Spiegel RJ
    J Clin Oncol; 1985 May; 3(5):654-9. PubMed ID: 3998782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferons in the treatment of multiple myeloma.
    Cooper MR
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):18-29. PubMed ID: 1948125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma.
    Musto P; Sajeva MR; Sanpaolo G; D'Arena G; Scalzulli PR; Carotenuto M
    Haematologica; 1997; 82(3):354-6. PubMed ID: 9234591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
    Mandelli F; Tribalto M; Avvisati G; Cantonetti M; Petrucci MT; Boccadoro M; Pileri A; Marmont F; Resegotti L; Lauta V
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():43-8. PubMed ID: 3277709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.